CVS · 10-Q · 2026Q2 · Full report

Capital Return Program

CVS HEALTH Corp · 2026-08-05 · Importance 50 · Surprise 24

CVS Health had two active share repurchase authorizations totaling $20.0 billion as of June 30, 2026. The November 2022 program had $10.0 billion remaining, while the December 2021 program had $1.5 billion remaining. The programs permit open-market, privately negotiated, accelerated share repurchase, and derivative transactions, and the Board may modify or terminate them. CVS Health repurchased no common shares during the six months ended June 30, 2026 or 2025.